投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 编号：TG1512-003 | --- | --- | --- | |-----------------------------|-----------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称及 | 宝盈基金管理有限公司 段鹏程 | | | 人员姓名 | | | | 时间 | 2015 年 12 月 | 14 日 9 ：30 至 11： 00 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | | | | | 上市公司接待人 | | 董秘兼财务负责人 田俊、证券事务代表兼证券总监 代 ...

Group 1: E-commerce Development - The company plans to leverage BW and HANA big data platforms to enhance e-commerce operations through data collection, analysis, and consumer behavior prediction [1] - Implementation of a CRM system aims to manage customer lifecycles and improve customer loyalty for both online and offline channels [1] - The logistics center will undergo technological upgrades to integrate store delivery and e-commerce services, enhancing logistics competitiveness [1] - The company aims to establish a vertical website focused on health products and services, utilizing an O2O model to strengthen online and offline business [1] Group 2: Market Expansion Strategy - The primary market is currently in the Southwest region, with additional presence in Hainan, Shanxi, Shanghai, and Tianjin [1] - Future development will focus on refining existing markets while gradually expanding into less competitive regions like Hainan and Shanxi [1] Group 3: Membership Management - The company has cultivated a stable member base in existing store markets, supported by a dedicated membership management system [2] - Strong member relationships have resulted in high brand loyalty and significant consumer retention [2] - The ongoing implementation of a CRM system will enhance customer data management and support marketing and sales decisions [3] Group 4: Professional Talent Development - The company actively recruits licensed pharmacists and conducts training programs to enhance the skills of existing employees [4] - Recent efforts in training and recruitment have yielded positive results in developing professional talent within the pharmacy sector [4]

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2015 年 12 月 30 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：电话访谈交流 投资者：国泰君安、中信证券、东北证券、兴业证券等 接待人：公司董事、 董事会秘书、副总裁、财务负责人 田俊 参加人员：证券事务代表兼证券总监代四顺、证券副总监李正红、财 务副总监肖冬磊、证券中心副经理卢国凤、证券事务主管王斌、证券 事务高级管理员田珂源 丁丹： 尊敬的各位投资者大家上午好，非常感谢大家在百忙之中抽出 时间参加国泰君安医药-一心堂定增方案调整解读电话会议，我是国 泰君安丁丹。众所周知，一心堂此次定增方案调整已公告相关事项。 为了让我们的投资者更好的了解公司的经营情况，我们特意邀请公 司领导董事会秘书田俊田总与各位投资者进行交流。 首先我们请一心堂董事会秘书兼财务负责人田俊田总解读此次 定增方案的调整的重要事项及其他相关情况，后续会留出时间给各 位投资者进行提问交流。 田总： 尊敬的各位参会投资者大家上午好，我是一心堂董秘兼 CFO 田 俊，首先我将本次定增方案及目前公司的基本概况向大家介绍下。 中国零售药店市场发展将会跟美 ...

Group 1: Investor Relations Activity - The activity involved a specific audience survey conducted by Guangfa Fund, represented by Qiu Jingmin [1] - The meeting took place on November 13, 2014, from 21:00 to 21:45 [1] - The location of the meeting was the conference room of Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd. [1] Group 2: Company Representatives - The meeting was attended by the company’s Secretary and Vice President, Tian Jun, and the Deputy Accounting Director, Li Zhenghong [1] Group 3: Main Content of the Activity - The primary focus of the investor relations activity was to discuss the company's business development [1]

Company Overview - Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd. was established on November 8, 2000, and transformed into a joint-stock company on May 10, 2009 [1]. Store Distribution - As of September 30, 2014, the company operates 2,480 directly-operated stores, with the majority located in Yunnan (1,915), followed by Guangxi (254), Sichuan (141), Chongqing (38), Shanxi (42), and Guizhou (90) [1]. Sales Growth of New Stores - New stores typically achieve profitability within 12 months and can recover initial losses by the 26th month. The average revenue per store continues to grow over time, although the growth rate decreases after six years of operation [1]. Revenue Growth Factors - The company attributes its revenue growth to strong channel advantages, sales execution, and marketing capabilities. Collaborations with suppliers enhance gross margins through various distribution models [2]. Rural Market Expansion - Increased government investment in rural healthcare is expected to boost personal healthcare spending among rural populations, which currently lags behind urban areas. This trend is anticipated to benefit the company as it expands its presence in rural markets [3]. Store Performance in Rural Areas - The number of rural stores has increased significantly, with sales and gross profits showing continuous growth post-healthcare reforms. The following table illustrates the growth in rural store numbers and retail revenue: | Year | Rural Store Count | Retail Revenue (万元) | |------------|-------------------|-----------------------| | 2011 | 160 | 13,276.25 | | 2012 | 277 | 19,396.75 | | 2013 | 383 | 28,545.78 | | 2014 (Jan-Sep) | 390 | 28,529.17 | - The company is focusing on expanding in third and fourth-tier cities and rural areas, which are seen as high-potential markets due to rising consumer incomes and health spending [4].

Group 1: Store Growth and Market Expansion - The slowdown in store growth in the first half of 2014 was due to the delay in the implementation of the new GSP certification standards, which affected new store approvals [2] - As of September 30, 2014, the company had 2,480 directly-operated stores, with the majority located in Yunnan (1,915), followed by Guangxi (254), Sichuan (141), and others [2][3] - The company expects to complete its planned store openings as the new GSP standards are implemented [2] Group 2: Sales Performance and Profitability - New stores typically achieve profitability within 12 months, with cumulative profits offsetting initial losses [2] - The average revenue per store continues to grow over time, although the growth rate may decline after six years of operation [2] - The company has established strong partnerships with suppliers, enhancing its marketing capabilities and improving gross margins [3][4] Group 3: Brand Co-Building and Financial Impact - The brand co-building model enhances the company's market position and brand recognition through private label products [4] - This model has positively impacted sales revenue and overall gross margin, contributing to increased profitability [4] Group 4: Rural Market Development - Government investments in rural healthcare are expected to boost personal healthcare spending among rural populations, which is currently lower than in urban areas [5] - The number of rural stores has increased from 160 in 2011 to 390 by September 2014, with retail revenue growing from 13,276.25 thousand yuan in 2011 to 28,529.17 thousand yuan in 2014 [6] - The rural market represents a significant growth opportunity for the company, especially as urbanization trends continue [6]

投资者关系活动记录表 证券代码：002727 证券简称：一心堂 云南鸿翔一心堂药业（集团）股份有限公司投资者关系活动记录表 编号：TG1505-001 | --- | --- | --- | |------------------------|-------------------------------|------------------------------------------------| | | | | | 投资者关系活动 | ■ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | ■ 其他 （电话会议） | | | 参与单位名称及 | 兴业证券等 164 | 人 | | 人员姓名 | | | | 时间 | 2015 年 5 月 | 20 日 15：00-17 ： 00 | | 地点 | | 云南鸿翔一心堂药业（集团）股份有限公司会议室 | | 上市公司接待人 | | 公司董事、 董事会秘书、副总裁、财务负责人 田俊 | | 员姓名 | 证券事务代表、证券总监 代四顺 | | | ...

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2015 年 3 月 10 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式：现场交流 投资者： 天弘基金郭相博、天弘基金刘盟盟、景林资产李朝、银 河证券李平祝、IDG 资本彭世泽、重阳投资胡敏、华泰证券何结领、李 璟、大禹投资黎仕禹、朱雀投资张皓、汇添富基金陈漳斌、兴业全球杨 世进、广发证券赵伟、中国人寿资产管理有限公司赵文龙、润晖投资 平晓川、王国进、国金证券姜英、信达证券孟阳、东方港湾凌军、上海 申银万国研究生周子露、长信基金陈益凌、华润元大基金张磊、上海 朴石投资毕海委、招商证券李勇、兴业证券邓晓倩、华夏基金邓湘伟、 冠亚集团陈真、溪牛投资管理周婷、中国银河证券霍辰伊、广州金骏 投资胡朝昀、上海铵盈投资杨海斌 接待人：董秘兼副总裁 田俊 参加人员: 董事长 阮鸿献、总裁 赵飚、副总裁 周红云、副总裁 伍 永军、董秘兼副总裁 田俊、证券事务代表兼证券总监 代四顺 问题一，公司电商业务的整体规划及核心竞争力是什么？ 答：电商业务的发展离不开强大的信息化基础支撑，截止现在，公司在信息化基础的 建设上已经累计投入超过 8000 ...

Group 1: Investor Relations Activity Overview - The investor relations activity involved multiple participants from various investment firms and securities companies [1] - The event took place on March 10, 2015, from 10:00 AM to 6:30 PM at the conference room of Yunnan Hongxiang Yixintang Pharmaceutical (Group) Co., Ltd. [2] - The activity type included specific object research and business development communication [3] Group 2: Key Personnel - The reception team included Chairman Ruan Hongxian, President Zhao Biao, and several Vice Presidents [3] - Notable attendees from investment firms included representatives from Tianhong Fund, IDG Capital, and Huatai Securities [1] Group 3: Activity Content - The main content of the investor relations activity focused on company business development discussions [3] - A record of questions raised during the on-site communication was maintained as an attachment [3]

云南鸿翔一心堂药业（集团）股份有限公司 投资者调研会议记录 时间：2015 年 6 月 24 日 地点：云南鸿翔一心堂药业（集团）股份有限公司会议室 召开方式： 现场交流 投资者：中國信託商業銀行李貞義，復華投信余文耀，統一投信林子欽、 陳朝政等 4 人 接待人：公司董事、 董事会秘书、副总裁、财务负责人 田俊 参加人员：财务证券中心财务副总监肖冬磊 一、公司定位：主学 CVS、兼修 walgreens 1、学习的逻辑：CVS 战略明确，锐意进取，而 walgreens 相对较为保守。 面对后者的强势地位，CVS 作为一个赶超者，采用持续并购战略迅速崛起。自 上世纪 60 年代就开始并购 Minute Clinic 、PBM 的 caremark，并维持每半年 并购一次。 2、中国的现实：由于发展历史的差距，中国很难创造全新的商业模式。同 时中国是一个断层社会，区域发展极其不平衡，因此与西方不同，在中国需要 同时在不同路径上同时演进，包括线上电商和线下诊所。 3、线下重磅出击：作为医药连锁行业的洋务派，公司年报中明确指出要学 习 CVS，当前自开门店已经满足不了资本市场的胃口，只有采取持续并购策略。 其中以 ...